Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 5/20 | 0.58 |
| ▸ | KDR | P35968 | 8/20 | 0.52 |
| ▸ | AURKA | O14965 | 3/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.45 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.45 |
| ▸ | KIT | P10721 | 1/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6426502 | 0.89 | KDR (0.46) | SNCAKDRAURKA | |
| SCHEMBL4144045 | 0.87 | KDR (0.67) | SNCAKDRAURKAFGFR1AURKB | |
| SCHEMBL4144047 | 0.87 | KDR (0.67) | SNCAKDRAURKAFGFR1AURKB | |
| SCHEMBL4146137 | 0.87 | KDR (0.48) | SNCAKDRAURKACSF1RPDGFRB | |
| SCHEMBL4146141 | 0.87 | KDR (0.48) | SNCAKDRAURKACSF1RPDGFRB | |
| SCHEMBL6426000 | 0.87 | KDR (0.48) | SNCAKDRAURKAFGFR1AURKB | |
| SCHEMBL4152214 | 0.85 | AURKA (0.55) | SNCAKDRAURKACSF1RPDGFRB | |
| SCHEMBL4152210 | 0.85 | AURKA (0.55) | SNCAKDRAURKACSF1RPDGFRB | |
| SCHEMBL4136114 | 0.84 | KDR (0.55) | SNCAKDRAURKAFGFR1 | |
| SCHEMBL4136121 | 0.84 | KDR (0.55) | SNCAKDRAURKAFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261339-A1 | Pyrazole compound and medicinal composition containing the same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261339-A1 | Pyrazole compound and medicinal composition containing the same | CNKSR1, NR3C2, CSNK2B | SNCA 2130/4885KDR 1044/4885AURKA 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.